EP 3344295 B1 20220223 - ANTI-SIALYL TN CHIMERIC ANTIGEN RECEPTORS
Title (en)
ANTI-SIALYL TN CHIMERIC ANTIGEN RECEPTORS
Title (de)
CHIMÄRE ANTI-SIALYL-TN-ANTIGENREZEPTOREN
Title (fr)
RÉCEPTEURS D'ANTIGÈNE CHIMÈRE TN ANTI-SIALYLE
Publication
Application
Priority
- KR 20150122727 A 20150831
- US 201662317950 P 20160404
- US 2016049493 W 20160830
Abstract (en)
[origin: WO2017040529A1] The invention provides improved compositions for adoptive cell therapies for cancers that express the glycoepitope STn on TAG-72.
IPC 8 full level
A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 14/705 (2006.01); C07K 16/00 (2006.01)
CPC (source: EP KR US)
A61K 39/001172 (2018.08 - US); A61K 39/4611 (2023.05 - EP KR); A61K 39/4631 (2023.05 - EP KR); A61K 39/464472 (2023.05 - EP KR); A61P 1/00 (2018.01 - EP); A61P 1/18 (2018.01 - EP); A61P 13/10 (2018.01 - EP); A61P 13/12 (2018.01 - EP); A61P 15/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP US); A61P 35/02 (2018.01 - EP); C07K 14/705 (2013.01 - KR); C07K 14/7051 (2013.01 - EP US); C07K 14/70517 (2013.01 - EP KR US); C07K 14/70521 (2013.01 - EP KR US); C07K 14/70578 (2013.01 - EP US); C07K 16/30 (2013.01 - KR); C07K 16/3076 (2013.01 - EP US); C07K 16/44 (2013.01 - EP US); C07K 19/00 (2013.01 - KR); A61K 2039/505 (2013.01 - EP US); A61K 2039/5156 (2013.01 - US); A61K 2039/5158 (2013.01 - US); A61K 2039/82 (2018.08 - EP US); A61K 2239/31 (2023.05 - EP KR); A61K 2239/38 (2023.05 - EP KR); C07K 2317/52 (2013.01 - KR); C07K 2317/53 (2013.01 - KR US); C07K 2317/56 (2013.01 - US); C07K 2317/622 (2013.01 - EP KR US); C07K 2317/70 (2013.01 - EP US); C07K 2317/73 (2013.01 - EP US); C07K 2319/02 (2013.01 - US); C07K 2319/03 (2013.01 - EP US); C07K 2319/33 (2013.01 - EP US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2017040529 A1 20170309; AU 2016315704 A1 20180405; AU 2016315704 B2 20220811; CA 2996893 A1 20170309; CN 108136014 A 20180608; EP 3344295 A1 20180711; EP 3344295 A4 20190501; EP 3344295 B1 20220223; EP 4014996 A1 20220622; ES 2911015 T3 20220517; JP 2018526028 A 20180913; JP 2021180676 A 20211125; JP 6980659 B2 20211215; KR 102715016 B1 20241011; KR 20180037294 A 20180411; US 11279769 B2 20220322; US 2019085092 A1 20190321
DOCDB simple family (application)
US 2016049493 W 20160830; AU 2016315704 A 20160830; CA 2996893 A 20160830; CN 201680059597 A 20160830; EP 16842821 A 20160830; EP 21217401 A 20160830; ES 16842821 T 20160830; JP 2018530657 A 20160830; JP 2021131289 A 20210811; KR 20187008875 A 20160830; US 201615755819 A 20160830